1. New Zealand Medicines and Medical Devices Safety Authority.Definity Data Sheet [Internet] 2008. Available from:http://www.medsafe.govt.nz/profs/Datasheet/d/Definityinj.pdf[cited 9 Aug 2018]
2. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version)
3. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – Update 2012: a WFUMB‐EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS;Claudon M;Ultraschall Med,2013
4. National Institute for Health and Care Excellence.SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast‐enhanced ultrasound imaging of the liver [Internet] 2012. Available from:https://www.nice.org.uk/guidance/dg5[15 Sep 2018]
5. Government of Western Australia.Focal Liver Lesion (Investigation) [Internet] 2015. Available from:http://www.imagingpathways.health.wa.gov.au/index.php/imaging-pathways/gastrointestinal/liver/investigation-of-a-focal-liver-nodule#pathway[15 Sep 2018].